Medicare Enrolled
Dr. Matthew Collins, D.O.
Cardiovascular Disease · Horsham, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Collins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Collins?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Collins
Dr. Matthew Collins is a cardiovascular disease specialist in Horsham, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Collins performed 2,607 Medicare services across 1,826 unique beneficiaries.
Between the years covered by Open Payments, Dr. Collins received a total of $5,643 from 40 pharmaceutical and/or device companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Collins is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 29% volume in PA
$5,643 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,607
Medicare services
Top 29% in PA for cardiovascular disease
1,826
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
543 | $11 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
393 | $84 | $186 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
308 | $6 | $56 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
221 | $99 | $193 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
125 | $7 | $35 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $66 | $123 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
97 | $130 | $222 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
89 | $26 | $71 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
88 | $18 | $42 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
78 | $144 | $335 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
77 | $16 | $97 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
69 | $165 | $800 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
57 | $171 | $346 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
56 | $20 | $97 |
| Heart muscle strain imaging | 40 | $32 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $108 | $239 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $71 | $133 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
25 | $17 | $26 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
22 | $17 | $83 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
21 | $27 | $190 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
20 | $2 | $92 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
19 | $16 | $175 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
19 | $11 | $175 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
17 | $56 | $240 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
17 | $89 | $995 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
15 | $20 | $72 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $19 | $101 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $121 | $273 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.6% high complexity
4.9% medium
86.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,643
Total received (2018-2024)
Avg $806/year across 7 years
Top 31% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
285
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,643 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,680
2023
$1,198
2022
$436
2021
$286
2020
$169
2019
$1,045
2018
$829
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$274
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$233
Merck Sharp & Dohme LLC
$212
Janssen Pharmaceuticals, Inc
$144
AstraZeneca Pharmaceuticals LP
$140
Actelion Pharmaceuticals US, Inc.
$122
ABIOMED
$80
Amgen Inc.
$75
PFIZER INC.
$66
Abbott Laboratories
$63
La Jolla Pharmaceutical Company
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
LANTHEUS MEDICAL IMAGING, INC.
$39
PROCYRION, INC.
$29
Lexicon Pharmaceuticals, Inc.
$26
Ethicon US, LLC
$25
United Therapeutics Corporation
$22
Kiniksa Pharmaceuticals International, plc
$19
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$943
Novartis Pharmaceuticals Corporation
$587
AstraZeneca Pharmaceuticals LP
$407
PFIZER INC.
$366
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$307
Abbott Laboratories
$237
AbbVie Inc.
$222
Merck Sharp & Dohme LLC
$212
SANOFI-AVENTIS U.S. LLC
$210
Boehringer Ingelheim Pharmaceuticals, Inc.
$205
Amgen Inc.
$176
Actelion Pharmaceuticals US, Inc.
$155
Impulse Dynamics (USA) Inc.
$151
BOSTON SCIENTIFIC CORPORATION
$139
Regeneron Healthcare Solutions, Inc.
$125
E.R. Squibb & Sons, L.L.C.
$114
Novo Nordisk Inc
$113
BIOTRONIK INC.
$107
Boston Scientific Corporation
$99
Bayer Healthcare Pharmaceuticals Inc.
$99
Medtronic Vascular, Inc.
$98
ABIOMED
$80
La Jolla Pharmaceutical Company
$54
ARALEZ PHARMACEUTICALS US INC.
$50
Amarin Pharma Inc.
$43
Alnylam Pharmaceuticals Inc.
$43
LANTHEUS MEDICAL IMAGING, INC.
$39
Lundbeck LLC
$33
PROCYRION, INC.
$29
Medtronic, Inc.
$27
Lexicon Pharmaceuticals, Inc.
$26
Ethicon US, LLC
$25
United Therapeutics Corporation
$22
Kiniksa Pharmaceuticals International, plc
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
Lantheus Medical Imaging, Inc.
$15
Merck Sharp & Dohme Corporation
$15
Relypsa, Inc.
$14
Aegerion Pharmaceuticals, Inc.
$12
iRhythm Technologies, Inc.
$11
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
AORTIX SYSTEM · Acticor 7 VR-T DX · Adempas · Alere i · Arcalyst · Azure · BRILINTA · CAMZYOS · CARDIOMEMS · CHANTIX · Confirm Rx · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · EVKEEZA · FARXIGA · GENERAL THERAPIES · GIAPREZA · HeartMate · HeartMate 3 Left Ventricular Assist Device · Impella · JARDIANCE · JOT DX · JUXTAPID · Kerendia · LEQVIO · LINQ II · LOKELMA · LifeVest · MULTAQ · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROLENE · QULIPTA · RESONATE · Renamic Neo · Repatha · Reveal LINQ · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
700
Per 100K population
81.3
County median income
$111,521
Nearest hospital
HORSHAM CLINIC
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Collins is a clinical cardiology specialist, with above-average Medicare volume (top 29% in PA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Collins experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Collins performed 543 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Collins receive payments from pharmaceutical companies?
Yes. Dr. Collins received a total of $5,643 from 40 companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Collins's costs compare to other cardiologists in Horsham?
Dr. Collins's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Collins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Horsham
Browse cardiologists in Horsham ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology